MYX 3.29% $4.40 mayne pharma group limited

Ann: Return of Capital - MYX (updated), page-59

  1. 3,894 Posts.
    lightbulb Created with Sketch. 2753
    The consolidation isn’t really the problem imo. It’s the failed capital management strategy around which it was wrapped and announced. They foolishly ran with a capital return & divi instead of a share buyback process; then they back-pedaled on the capital return, signalling a return to the bad old days of unreliability; they have not moved swiftly to list the business in the US and announce that immediately following consolidation which would’ve been the ideal time; they have yet to address the insane goodwill figure still on the balance sheet; and now they are understandably drifting without anchor. Consolidation could’ve worked - or at least had minimal downside - had they strategically and swiftly kicked into gear with all the other moving parts.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.